This Special Notice opportunity from New York was posted on October 13, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Bid Extension: 81627Y0870-INSTI HIV-1/2 Test kits and INSTI Control Test kits
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The New York City Department of Health and Mental Hygiene intends to enter into a six-year agreement with Biolytical Laboratories Inc. for the procurement of INSTI HIV-1/HIV-2 Rapid Antibody Tests and Test Controls. These supplies will be used on an as-needed basis by the Bureau of HIV's Field Services Unit and various Sexually Transmitted Disease clinics across New York City to facilitate the rapid detection of HIV antibodies. Biolytical Laboratories Inc. has been identified as the sole source provider and manufacturer of these specific branded products, meaning they are sold exclusively by the company without resellers or distributors. Interested firms capable of legally providing these goods may submit an Expression of Interest via the PASSPort system for RFI EPIN 81627Y0870 by October 30, 2026, at 2:00 PM.
General Info
Place of Performance
Not specifiedSet-Aside
Documents
0No documents available
Documents will appear here when they are available.
AI Contract Breakdown
Uniform Contract FormatNo documents to break down
The breakdown needs solicitation documents. None were found from this contract's source.
Timeline
Submission Closed
Organization & Contact Information
Full Description
Pursuant to Section 3-05 of the New York City Procurement Policy Board Rules, the Department of Health and Mental Hygiene (DOHMH) intends to enter into negotiations for a six-year agreement with Biolytical Laboratories Inc. to provide INSTI® HIV-1/HIV-2 Rapid Antibody Tests and INSTI® HIV-1/HIV-2 Test Controls on an as needed basis. These products will be utilized by DOHMH's Bureau of HIV's Field Services Unit and in DOHMH`s Sexually Transmitted Disease (STD) Clinics throughout NYC for rapid detection of HIV antibodies.
DOHMH has determined that Biolytical Laboratories Inc. is the sole source provider of these products. BioLytical Laboratories Inc. is the sole manufacturer and seller of the branded INSTI® HIV Test, all INSTI® HIV Test products are manufactured and sold exclusively by BioLytical Laboratories Inc. and must be purchased directly from them. There are no resellers or distributors for these products.
Any firm that believes it can legally provide these goods, is invited to submit an Expression of Interest directly to this RFI- EPIN 81627Y0870 no later than 10/30/2026 by 2:00PM.
Correspondences must be posted directly in PassPort to this RFI; any communication outside of this RFI will not be accepted.
If you need additional assistance with PASSPort, please contact the MOCS Service Desk at https://mocssupport.atlassian.net/servicedesk/customer/portal/8
PIN: 81627Y0870
More opportunities from New York → Health And Mental Hygiene
Same awarding agency
Earlier notices in this NAICS code
Posted before this notice, open and closed
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
